foxo4-dri senolytic peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Molecular modelling of the FOXO4-TP53

BPC-157 Standalone Targeted tissue repair and inflammation support A synthetic peptide derived from a naturally occurring protein, BPC-157 promotes angiogenesis, improves blood flow to damaged areas, and supports healing across musculoskeletal and gastrointestinal systems at the cellular level

Expiration Our products are potent and made fresh, they have a 35-45 day shelf-life because we like to minimize the use of extra preservatives

H.El-MagdM

Key significance: Proof-of-concept that mitochondria-targeted peptides can reach FDA approval For the complete regulatory timeline, see our Elamipretide FDA approval status guide

Can BPC-157 replace medical treatment

Add 1 mL to 2 mL of bacteriostatic water to the lyophilized BPC-157 vial using a sterile syringe, swirling gently to dissolve without shaking